RE:RE:Thanks for the email, I’ll answer your questions publiclyVery interesting. I’ve had BioFluffPump on Ignore for quite a while now. I remember he always said 2020 was his target, and LMAO, he now has gone to EOY 2022 !!! Another timeline pump gone out the window, and down the drainpipe. And only $10 almost 5 yrs from now!! What happened to $100 by that time. My guess is, we will be lucky, very lucky, for $5 at that time.
We
DrillMonkey wrote: Interesting Bio, that’s EXACTLY what I get based on a 1 billion share float fully diluted, with $2 billion in annual sales for all products (Ryplazim, IVIG, 4050, etc), and a 5x multiple of sales. I also share your exact timeline too. Factor in a 5:1 rollback and $50 per share is the number with 200 million outstanding. Hopefully management doesn’t f@kc this up anymore.
Biofinder wrote: PLI, HD, AMGN, VZ, XOM (current mix of stocks)
PLI:
My thinking (Thesis) on PLI is a 5:1 reverse split, meaning (for example) 100,000 PLI shares would become 20,000 PLI shares overnight.
By EOY 2022, if Ryplazim and PBI-4050 are as successful as my thesis anticipates, and the market size is as large as I have calculated, I’m guessing a $50 sp is not out of the question, which would mean $1,000,000 USD gross for the exampled 20,000 PLI shares. Throw in the mix that I’m gambling on a “company buyout” sometime in the future, and your guess becomes is as good as mine as to where the sp will finally end up.
This is what I’m gambling on, and this is my “current” thesis on PLI.
(Thesis = my guesses based on reading)